Pharma Foods International Co., Ltd. (TYO:2929)
564.00
-1.00 (-0.18%)
Nov 13, 2026, 3:25 PM JST
TYO:2929 Revenue
In the fiscal year ending July 31, 2026, Pharma Foods International had annual revenue of 63.22B JPY, down -3.12%. Pharma Foods International had revenue of 14.67B in the quarter ending July 31, 2026, a decrease of -20.47%. That makes Pharma Foods International the 12,680th largest company in the world by revenue and 1,309th in Japan.
Revenue
63.22B
Revenue Growth
-3.12%
P/S Ratio
0.26
Revenue / Employee
101.16M
Employees
625
Market Cap
16.38B
Revenue by Segment
- B to C Business 55.37B 87.6%
- B to B Business 7.47B 11.8%
- Bio Medical Business 350.00M 0.6%
- Other 33.00M 0.1%
Fiscal year ended Jul 31, 2026 See the full TYO:2929 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2026 | 63.22B | -2.04B | -3.12% |
| Jul 31, 2025 | 65.26B | 3.11B | 5.01% |
| Jul 31, 2024 | 62.15B | -6.43B | -9.37% |
| Jul 31, 2023 | 68.57B | 8.39B | 13.94% |
| Jul 31, 2022 | 60.19B | 13.43B | 28.73% |
| Jul 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| ASKA Pharmaceutical Holdings | 71.50B |
| Fuso Pharmaceutical Industries,Ltd. | 62.85B |
| Fuji Pharma | 62.39B |
| Daito Pharmaceutical | 49.53B |
| Nippon Chemiphar | 32.98B |
| Koa Shoji Holdings | 24.50B |
| Morishita Jintan | 12.84B |
| Mizuho Medy | 10.82B |